---

Graziella Pellegrini

Cell Therapy Program Coordinator, center for Regenerative Medicine “Stefano Ferrari”, University of Modena and Reggio Emilia

After studying chemistry and pharmaceutical Technologies, Graziella went on to become a leading figure in the field of epithelial stem cell biology aimed at clinical applications in cell and gene therapy. She was involved in the development of the first stem cell-based advanced therapy medicinal product approved in Europe – Holoclar.

---

Part of the Power List 2018

The World’s Top 100 Medicine Makers

Bringing new drugs to patients is an incredibly difficult task that involves numerous indispensable actors – from pioneering entrepreneurs and CEOs, to industry experts, to dedicated researchers, to regulators who keep everyone on the right tracks.

Go to The Power List 2018